Increased rates of hospital-onset Staphylococcus aureus bacteraemia in National Health Service acute trusts in England between June 2020 and March 2021: a national surveillance review.

Autor: Mason E; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK. Electronic address: emily.l.mason@ukhsa.gov.uk., Nsonwu O; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Elmes J; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Chudasama D; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Pearson C; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Hasan L; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Hope R; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK., Gerver SM; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, Clinical & Public Health Group, UK Health Security Agency, London, UK.

Publikováno v: The Journal of hospital infection [J Hosp Infect] 2024 Jan; Vol. 143, pp. 33-37. Date of Electronic Publication: 2023 Oct 29.

Intermittent point prevalence surveys on healthcare-associated infections, 2011 and 2016, in England: what are the surveillance and intervention priorities?

Autor: Henderson KL; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK. Electronic address: Katherine.henderson@ukhsa.gov.uk., Saei A; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK., Freeman R; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK., Johnson AP; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK., Ashiru-Oredope D; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK., Gerver SM; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK., Hopkins S; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.

Publikováno v: The Journal of hospital infection [J Hosp Infect] 2023 Oct; Vol. 140, pp. 24-33. Date of Electronic Publication: 2023 Jul 31.

Increase in invasive group A streptococcal infection notifications, England, 2022.

Autor: Guy R; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Henderson KL; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Coelho J; Staphylococcus and Streptococcus Reference Section, AMRHAI, UK Health Security Agency, London, United Kingdom., Hughes H; Real-time Syndromic Surveillance Team, Field Services Division, UK Health Security Agency, London, United Kingdom., Mason EL; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Gerver SM; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Demirjian A; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom.; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, United Kingdom.; Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Watson C; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom., Sharp A; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Brown CS; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom., Lamagni T; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, United Kingdom.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Jan; Vol. 28 (1).

Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data.

Autor: Llewelyn MJ; Global Health and Infectious Diseases, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PS, UK.; Department of Microbiology and Infection, University Hospitals Sussex NHS Foundation Trust, Brighton, BN2 5BE, UK., Grozeva D; Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Howard P; School of Healthcare, University of Leeds, Leeds, LS2 9JT, UK.; Pharmacy Department, Leeds Teaching Hospitals, Leeds, LS1 3EX, UK., Euden J; Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Gerver SM; Division of Healthcare Associated Infections and Antimicrobial Resistance, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Hope R; Division of Healthcare Associated Infections and Antimicrobial Resistance, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Heginbothom M; Healthcare Associated Infection, Antimicrobial Resistance and Prescribing Programme, Public Health Wales, 2 Capital Quarter, Tyndall St, Cardiff, CF10 4BZ, UK., Powell N; Pharmacy Department, Royal Cornwall Hospital Trust, Truro, TR1 3LJ, UK., Richman C; Rx-Info Ltd, Exeter Science Park, 6 Babbage Way, Exeter, EX5 2FN, UK., Shaw D; NIHR Respiratory Biomedical Research Centre, University of Nottingham, Nottingham, NG5 1PB, UK., Thomas-Jones E; Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., West RM; University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9LU, UK., Carrol ED; Department of Clinical Infection, Microbiology and Immunology, University of Liverpool Institute of Infection, Veterinary and Ecological Sciences, Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK., Pallmann P; Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK., Sandoe JAT; Department of Microbiology, The Old Medical School, The General Infirmary at Leeds, Leeds, LS1 3EX, UK.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Mar 31; Vol. 77 (4), pp. 1189-1196.

National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.

Autor: Gerver SM; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK. Electronic address: sarah.gerver@phe.gov.uk., Guy R; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Wilson K; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Thelwall S; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Nsonwu O; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Rooney G; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Brown CS; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Muller-Pebody B; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Hope R; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK., Hall V; Healthcare-Associated Infection & Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Nov; Vol. 27 (11), pp. 1658-1665. Date of Electronic Publication: 2021 Jun 08.